研究概要
我们报告首例在接受 ICI 治疗后因转移性肾细胞癌接受手术、且肾脏病理诊断为 SLR 的患者。
研究思路结论见上方概要
背景
免疫检查点抑制剂(ICIs)可用于转移性肾细胞癌的治疗。ICIs与多种免疫相关不良事件(irAEs)相关,其中之一是类肉瘤反应(SLR)。SLR通常难以与癌症进展相区分。病例介绍:患者为71岁女性。她因透明细胞肾细胞癌伴股骨骨转移接受4个疗程的ipilimumab + nivolumab治疗后,接受了腹腔镜肾切除术。在病理检查中,除TIL(肿瘤浸润淋巴细胞)外,肿瘤内还发现大量非干酪样上皮样细胞肉芽肿。在不符合系统性结节病诊断标准的患者中出现非干酪样上皮样细胞肉芽肿,被认为是由于ICI引起的SLR。
展开英文摘要原文
INTRODUCTION: Immune checkpoint inhibitors (ICIs) are useful in the treatment of metastatic renal cell carcinoma. ICIs have been associated with a variety of immune-related adverse events (irAEs), one of which is a sarcoid-like reaction (SLR). SLR is often difficult to distinguish from cancer progression.
CASE PRESENTATION: The patient is a 71-year-old woman. She underwent laparoscopic nephrectomy after 4 courses of ipilimumab + nivolumab therapy for clear cell renal cell carcinoma with femoral bone metastasis. In the pathological examination, in addition to tumor-infiltrating lymphocytes, numerous non-caseating epithelioid cell granulomas were found in the tumor. The occurrence of non-caseating epithelioid cell granuloma in a patient who did not meet the diagnostic criteria for systemic sarcoidosis was considered SLR due to ICI.
CONCLUSIONS: We report the first case of a patient who underwent surgery for metastatic renal cell carcinoma after treatment with ICI and who was pathologically diagnosed with SLR in the kidney.
论文信息
- 作者
- Fukushima K、Mizukoshi S、Ino T、Ishida T、Ito Y、Okimura A、Nakatsugawa M、Hashimoto T
- 单位
- Department of Urology Tokyo Medical University Hachioji Medical Center Tokyo Japan.Japan
- 期刊
- IJU case reports2025 May